StockMarketWire.com - Heart-health focused food additive supplier Provexis booked a full-year loss after rising revenue was offset by R&D spending.

Pre-tax losses for the year through March amounted to £0.53m, compared to losses of £0.47m on-year.

Revenue rose 37% to £0.32m, offset by higher R&D spending primarily due to blood-pressure-lowering patent application costs.

At 9:47am: [LON:PXS] Provexis PLC share price was 0p at 0.3p



Story provided by StockMarketWire.com